Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus

Pediatric Infectious Disease Journal

Volumn 16, Issue 2, 1997, Pages 200-204

  Jackson, Cynthia R ^a,b,d   Vavro, Cindy L ^b   Valentine, Megan E ^a   Pennington, Kevin N ^b   Lanier, E Randall ^b   Katz, Samuel L ^a   Diliberti, John H ^c   Mckinney, Ross E ^a   Wilfert, Catherine M ^a   St Clair, Marty H ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Human immunodeficiency virus; influenza vaccine; pediatric(s); viral load

Indexed keywords

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS REPLICATION;

ADOLESCENT; ANTIBODIES, VIRAL; CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; MALE; VACCINATION; VIRAL LOAD;

EID: 0031055080     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199702000-00007     Document Type: Article

References (20)

1. Serewint JR, Miller RM, Korsch BM. Influenza type A and B infections in hospitalized pediatric patients: who should be immunized? Am J Dis Child 1991;145:623-6.
2. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. Prevention and control of influenza. MMWR 1995;44(RR-3): 1-22.
3. Chadwick EG, Chang G, Decker MD, Yogev R, DiMichelle D, Edwards K. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13:206-11.
4. Fultz PN, Guckman JC, Muchmore E, Girard M. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res Hum Retroviruses 1992;8:313.
5. Ho DD. HIV-1 viraemia and influenza. Lancet 1992;339:1549.
6. Janoff EN, Swindells S, Brichacek B, Stevenson M, Increased HIV-1 burden with immune activation following immunization with pneumococcal vaccine. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Session 134, San Francisco, CA, September 17 to 20, 1995.
7. O'Brien WA, Grovit-Ferbas K, Namaze A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;3:1082-9.
8. Brichacek B, Swindells S. Pirruccello S, et al. Increase in HIV-1 replication following vaccination against opportunistic infections [Abstract D4-204]. Presented at the HIV Pathogenesis Symposium, 24th Annual Keystone Symposia, Keystone, CO, April 17 to 23, 1995.
9. Yerly S, Wunderli W, Wyler CA, et al. Influenza immunization of HIV-1 infected patients does not increase HIV-1 viral load. AIDS 1994;8:1503-4.
10. Ramilo O, Hicks PJ, Borvak J, et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 1996; 15:197-203.
11. Jackson JB, Coombs RW, Sannerud K, Rhame FS, Balfour HH Jr. Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol 1988;26: 1416-18.
12. Shwartz O, Henin Y, Marechal V, Montagnier L. A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses 1988;4:441-8.
13. Harada S, Koyangi Y, Yamamoto N. Infection of HTLV-III/ LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985;229:563-6.
14. Urdea MS. Branched DNA signal amplification. Biotechnology 1994;12:926-7.
15. Urdea MS, Wilber JC, Yeghiazarian T, et al. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993; 7(Suppl. 2):S11-14.
16. Dewar RL, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994;170:1172-9.
17. Wright PF, Okabe N, McKee KT, et al. Cold-adapted recombinant influenza A virus vaccine in seronegative young children. J Infect Dis 1982;146:71-9.
18. Connor RI, Mohr H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67: 1772-7.
19. Nelson, KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 1988;109:383-8.
20. Rose DN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993;94:160-8.